Chimera Bioengineering
Chimera Bioengineering is a biotechnology company developing cell therapies to treat cancer.
All edits
' fill='white' fill-rule='nonzero'%3e%3cpath d='M52 12c-22.048 0-40 17.952-40 40 0 10.848 4.48 21.376 12.288 28.864 7.008 6.752 16.096 10.592 25.792 11.04.48.032.992.096 1.472.096H52c10.336 0 20.128-3.904 27.616-11.04C87.616 73.312 92 63.04 92 52c0-22.048-17.952-40-40-40zm26.912 65.056c-1.472-5.216-8.448-8.032-13.696-10.112l-1.792-.736C60 64.8 60 63.488 60 61.6c0-1.344.672-3.264 1.888-4.416 3.104-2.72 4.736-6.464 4.736-10.816 0-8.8-6.144-15.168-14.624-15.168-8.448 0-14.336 6.24-14.336 15.168 0 4.544 1.536 8.192 4.512 10.816 1.248 1.12 1.792 3.072 1.792 4.416 0 1.344 0 3.008-4.16 4.704-5.12 2.112-11.904 4.992-15.008 10.432C18.688 69.984 15.2 61.12 15.2 52c0-20.288 16.512-36.8 36.8-36.8 20.288 0 36.8 16.512 36.8 36.8 0 9.408-3.52 18.208-9.888 25.056z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
August 25, 2017
On August 25, 2017 Chimera Bioengineering completed their seed funding round with an undisclosed amount of funding from Kairos Venture Investments.
November 16, 2016
On November 16, 2016 Chimera Bioengineering raised an undisclosed amount of venture capital funding from The Angel's Forum and Sand Hill Angels.
Chimera Bioengineering is a biotechnology company developing cell therapies to treat cancer that is headquartered in South San Francisco, California and was founded in 2015 by Ben Wang, Christina Smolke, and Gusti Zeiner.
On November 16, 2016 Chimera Bioengineering raised an undisclosed amount of venture capital funding from The Angel's Forum and Sand Hill Angels.
On August 25, 2017 Chimera Bioengineering completed its seed funding round with an undisclosed amount of funding from Kairos Venture Investments.
On May 28, 2019 Chimera Bioengineering raised $16.3M in a venture round of funding.
Find more companies like Chimera Bioengineering
